AIM ImmunoTech Statistics

Total Valuation

AIM ImmunoTech has a market cap or net worth of $16.46 million. The enterprise value is $9.32 million.

Market Cap	16.46M
Enterprise Value	9.32M

Important Dates

The next estimated earnings date is Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

AIM ImmunoTech has 63.32 million shares outstanding. The number of shares has increased by 3.57% in one year.

Shares Outstanding	63.32M
Shares Change (YoY)	+3.57%
Shares Change (QoQ)	+6.83%
Owned by Insiders (%)	8.62%
Owned by Institutions (%)	6.86%
Float	53.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	62.90
Forward PS	n/a
PB Ratio	2.37
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	46.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.55.

Current Ratio	1.17
Quick Ratio	1.14
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-125.85

Financial Efficiency

Return on equity (ROE) is -154.79% and return on invested capital (ROIC) is -97.74%.

Return on Equity (ROE)	-154.79%
Return on Assets (ROA)	-80.04%
Return on Capital (ROIC)	-97.74%
Revenue Per Employee	$7,179
Profits Per Employee	-$1.00M
Employee Count	28
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.50% in the last 52 weeks. The beta is -0.39, so AIM ImmunoTech's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-43.50%
50-Day Moving Average	0.29
200-Day Moving Average	0.37
Relative Strength Index (RSI)	45.73
Average Volume (20 Days)	274,977

Short Selling Information

The latest short interest is 509,932, so 0.81% of the outstanding shares have been sold short.

Short Interest	509,932
Short Previous Month	498,079
Short % of Shares Out	0.81%
Short % of Float	0.95%
Short Ratio (days to cover)	1.28

Income Statement

In the last 12 months, AIM ImmunoTech had revenue of $201,000 and -$28.05 million in losses. Loss per share was -$0.56.

Revenue	201,000
Gross Profit	143,000
Operating Income	-31.59M
Pretax Income	-31.12M
Net Income	-28.05M
EBITDA	-31.36M
EBIT	-31.59M
Loss Per Share	-$0.56

Full Income Statement

Balance Sheet

The company has $10.06 million in cash and $3.36 million in debt, giving a net cash position of $6.70 million or $0.11 per share.

Cash & Cash Equivalents	10.06M
Total Debt	3.36M
Net Cash	6.70M
Net Cash Per Share	$0.11
Equity (Book Value)	6.10M
Book Value Per Share	0.11
Working Capital	1.52M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-23.25M
Capital Expenditures	n/a
Free Cash Flow	-23.25M
FCF Per Share	-$0.37

Full Cash Flow Statement

Margins

Gross Margin	71.14%
Operating Margin	-15,715.92%
Pretax Margin	-13,952.74%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-11,623.83%

Dividends & Yields

AIM ImmunoTech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.57%
Shareholder Yield	-3.57%
Earnings Yield	-175.06%
FCF Yield	-145.14%

Analyst Forecast

The average price target for AIM ImmunoTech is $3.00, which is 1,054.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.00
Price Target Difference	1,054.29%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	202.96%
EPS Growth Forecast (5Y)	-21.14%

Stock Forecasts

Stock Splits

The last stock split was on June 11, 2019. It was a reverse split with a ratio of 0.022727273:1.

Last Split Date	Jun 11, 2019
Split Type	Reverse
Split Ratio	0.022727273:1

Scores

AIM ImmunoTech has an Altman Z-Score of -42.18 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-42.18
Piotroski F-Score	2